Healthy Extracts Inc. 2025 Annual Report: Key Points for Investors

Summary of the Report

Healthy Extracts Inc. (“the Company”) has released its Form 10-K Annual Report for the fiscal year ended December 31, 2025. The report provides a comprehensive overview of the company’s activities, financial condition, risks, and strategic direction. Key highlights and issues that may be of particular interest to shareholders and could impact share value are detailed below.

Key Financial and Operational Highlights

• Net Loss and Going Concern: The Company reported a net loss of \$20,121,462 from inception through December 31, 2025. As of the same date, cash resources were limited, with only \$9,935 on hand. The auditor’s report specifically raises substantial doubt about the Company’s ability to continue as a going concern, citing the need for additional capital and significant operating revenues to assure continuation. If the Company is unable to secure new financing, business failure and loss of shareholder investment are a risk.
• Share Structure and Public Float: As of March 31, 2026, there were 16,890,868 shares of common stock outstanding. The aggregate market value of voting and non-voting common equity held by non-affiliates was \$4,083,170, based on a closing price of \$2.00 per share as of June 30, 2025. Notably, over 75% of outstanding shares are owned by a single shareholder, Donald Swanson, giving him substantial influence over all matters submitted to shareholders.
• Growth Through Acquisition: The Company acquired Gummy USA in October 2025, accelerating revenue growth and boosting gross profit. Management expects future growth to be driven by new product launches (supplements for CoQ10, weight management, hydration, and gut health), as well as expansion of natural formulations for heart and brain health.
• Strategic Focus: The Company’s business model centers on acquiring, developing, patenting, marketing, and distributing plant-based and natural supplement products. Recent acquisitions and product launches are part of a broader strategy to diversify product offerings and expand sales channels.

Risks and Issues That May Affect Share Value

• Dependence on Key Supplier: Healthy Extracts relies predominantly on a single supplier for licensing and manufacturing. Termination of this agreement could have a material adverse effect on product cost and manufacturing capability, particularly until in-house manufacturing is ramped up.
• Profitability Concerns: The Company is not currently profitable. Management expresses hope that new product introductions and stable cash flow will lead to profitability, but there is no assurance of future profits. Failure to generate sufficient revenues may result in suspension or cessation of operations.
• Market and Regulatory Risk: The Company’s success is closely tied to the size and growth rate of the vitamins, minerals, and supplements market. Adverse changes in this sector or negative media attention regarding nutritional supplements could materially impact the business.
• Liquidity and Dilution Risk: The Company will require additional financing to support growth, and there is no guarantee such funding will be available on favorable terms. Any new equity issuance is likely to be dilutive to existing shareholders.
• Competition: Healthy Extracts faces intense competition from larger, more established companies with greater resources. If competitors develop more appealing, safer, or less expensive products, the Company’s market share and profitability could be threatened.
• Control by Principal Shareholder: Donald Swanson’s control of over 75% of outstanding shares allows him to substantially influence or determine the outcome of any matter submitted for shareholder approval, including director elections and major corporate transactions.
• Product Acceptance and Unsold Inventory: The Company has a significant amount of unsold inventory, which could affect assets and profitability. There is also risk that new products may not be accepted by the market.
• Potential for Substantial Share Price Volatility: The stock is thinly traded on the OTCQB, and a large portion of shares are restricted but could become eligible for sale, potentially causing significant share price declines.
• Legal and Compliance Costs: As a small public company, Healthy Extracts faces increased compliance costs under Sarbanes-Oxley and other SEC rules, which will require management attention and may increase operating expenses.
• Dividends: The Company does not anticipate paying dividends in the foreseeable future. Capital appreciation, if any, will be the only source of gain for investors.
• Intellectual Property: The Company does not currently have material patent, trademark, or copyright protection for its core business, which could expose it to competitive risks.

Important Details for Shareholders

• Going Concern Warning: The explicit warning from the auditor regarding the Company’s ability to continue as a going concern is highly material and may impact share value.
• Heavy Insider Control: The overwhelming ownership by a single shareholder may deter some investors and can dramatically affect share price in the event of any change in control or disposition of shares.
• Potential Dilution: Any future capital raises, especially through equity, will likely dilute existing shareholders.
• Low Liquidity and Penny Stock Risks: The Company’s shares are classified as penny stock, which entails additional regulatory requirements and may further reduce liquidity and deter institutional investment.
• Strategic Uncertainty: While the Company is pursuing growth through acquisitions and new product lines, integration risks, execution risk, and potential for unsuccessful acquisitions are high.
• No Legal or Regulatory Proceedings: The report notes no legal proceedings involving officers or directors and no mine safety disclosures.

Conclusion

Investors should be acutely aware of the Company’s precarious financial position, dependence on key suppliers and personnel, lack of profitability, and the potential for significant dilution and volatility in the share price.
While Healthy Extracts Inc. is executing an ambitious growth and acquisition strategy, substantial risks remain, including the possibility of business failure if new financing or profitability is not achieved in the near term.

Any of the above factors, especially the going concern warning and potential dilution, may be price sensitive and could lead to significant share price movements in either direction.

Disclaimer: This article is a summary and interpretation of the company’s 2025 Form 10-K Annual Report and is for informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any securities. Investors should perform their own due diligence and consult a qualified financial advisor before making investment decisions. The author is not responsible for any actions taken based on this article.

View HEALTHY EXTRACTS INC. Historical chart here